Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Immunotherapies: A revolution in cancer treatment, but are they accessible for all patients?

Innovative Medicines Initiative: Calling for research on immunotherapies?

Date

29 Sep 2019

Session

Immunotherapies: A revolution in cancer treatment, but are they accessible for all patients?

Topics

Management of Systemic Therapy Toxicities; Bioethical Principles and GCP; Tumour Immunology; Immunotherapy; Translational Research; Supportive Care and Symptom Management

Tumour Site

Presenters

Kjetil Tasken

Authors

K. Tasken

Author affiliations

Dept. Of Cancer Immunology, Oslo University Hospital - The Norwegian Radium Hospital, 0424 - Oslo/NO

Resources

If you do not have an ESMO account, please create one for free.

Resources from the same session

29 Sep 2019

Immunotherapy 101

Presenter: Christian Blank

Session: Immunotherapies: A revolution in cancer treatment, but are they accessible for all patients?

Resources:

Slides

Webcast

29 Sep 2019

Case study: NSCLC

Presenter: Miklos Pless

Session: Immunotherapies: A revolution in cancer treatment, but are they accessible for all patients?

Resources:

Slides

Webcast

29 Sep 2019

State of play in the EU & beyond: Accessible or not?

Presenter: André Ilbawi

Session: Immunotherapies: A revolution in cancer treatment, but are they accessible for all patients?

Resources:

Slides

Webcast

29 Sep 2019

Patient perspective

Presenter: Bettina Ryll

Session: Immunotherapies: A revolution in cancer treatment, but are they accessible for all patients?

Resources:

Slides

Webcast